Menu
My Power Options system identifies the most volatile and liquid stocks for option trading or short-term stock trading, and this week it’s showing overall weakness in the hospital supply, management and pharmaceutical areas. More
For the current week, the overall ratings of six Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Two of Novartis' flu vaccines have been banned in seven countries, but the market's reaction to the move may be a bit overdone. Here's why. More
Researchers at Sea Lane Biotechnologies and Scripps Research Institute have discovered an antibody that stops the flu virus from attaching to healthy cells. More
A look through Big Pharma's drug pipelines shows a lot of promise across several companies, but one firm stands out as having big-time revenue growth potential. More
If you're convinced the bear is eventually coming back to bite us, consider getting into one or all of these five mutual funds with defensive postures. More
AstraZeneca has named Pascal Soriot, the chief operating officer of Roche's pharmceutical business, as its new CEO, replacing David Brennan, who left in June. More
Sponsored By:
Sponsored By:
